One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
PD-1 or PD-L1 Blockade Adds Little to Combination of BRAF and MEK Inhibition in the Treatment of BRAF V600-Mutated Melanoma.
Callahan, Margaret K. MD, PhD 1,; Chapman, Paul B. MD 2,,
doi : 10.1200/JCO.21.02801
Volume 40(13) pgs. 1393-1509 May 1, 2022
Radioactive Iodine: Recognizing the Need for Risk-Benefit Balance.
McDonald, Andrew M. MD, MS 1,2,,; Lindeman, Brenessa MD, MEHP 3; Bahl, Deepti MD 4
doi : 10.1200/JCO.22.00013
Late Recurrence Following Early Breast Cancer.
Thomas, Alexandra MD 1,,; Parsons, Heather A. MD, MPH 2,; Smith, Karen Lisa MD, MPH 3,
doi : 10.1200/JCO.22.00167
Linking Structural Racism and Discrimination and Breast Cancer Outcomes: A Social Genomics Approach.
Carlos, Ruth C. MD, MS 1,,; Obeng-Gyasi, Samilia MD, MPH 2; Cole, Steven W. PhD 3,; Zebrack, Bradley J. MPH, MSW, PhD 1; Pisano, Etta D. MD 4,; Troester, Melissa A. PhD 5; Timsina, Lava PhD 6; Wagner, Lynne I. PhD 7,; Steingrimsson, Jon A. PhD 8; Gareen, Ilana PhD 8; Lee, Christoph I. MD, MS, MBA 9,; Adams, Alyce S. PhD, MPP 10,; Wilkins, Consuelo H. MD, MSCI 11
doi : 10.1200/JCO.21.02004
Risk and Outcome of Breakthrough COVID-19 Infections in Vaccinated Patients With Cancer: Real-World Evidence From the National COVID Cohort Collaborative.
Song, Qianqian PhD 1; Bates, Benjamin MD 2,,; Shao, Yu Raymond MD, PhD 3,; Hsu, Fang-Chi PhD 1; Liu, Feifan PhD 4,; Madhira, Vithal MS 5; Mitra, Amit Kumar PhD 6; Bergquist, Timothy PhD 7,; Kavuluru, Ramakanth PhD 8,; Li, Xiaochun PhD 9,; Sharafeldin, Noha MD, PhD, MSc 10; Su, Jing PhD 9,; Topaloglu, Umit PhD 1,
doi : 10.1200/JCO.21.02419
Randomized Phase III Trial Evaluating Spartalizumab Plus Dabrafenib and Trametinib for BRAF V600-Mutant Unresectable or Metastatic Melanoma.
Dummer, Reinhard MD 1,,; Long, Georgina V. MD 2,; Robert, Caroline MD 3,; Tawbi, Hussein A. MD 4,; Flaherty, Keith T. MD 5,; Ascierto, Paolo A. MD 6,; Nathan, Paul D. MD 7,; Rutkowski, Piotr MD 8,; Leonov, Oleg MD 9; Dutriaux, Caroline MD 10,; Mandala, Mario MD 11,12,; Lorigan, Paul MBBCh 13,; Ferrucci, Pier Francesco MD 14,; Grob, Jean Jacques MD 15,; Meyer, Nicolas MD 16,; Gogas, Helen MD 17,; Stroyakovskiy, Daniil MD 18,; Arance, Ana MD 19,; Brase, Jan C. PhD 20,; Green, Steven MSc 20,; Haas, Tomas PhD 20,; Masood, Aisha MD 21,; Gasal, Eduard MD 21,; Ribas, Antoni MD 22,; Schadendorf, Dirk MD 23,
doi : 10.1200/JCO.21.01601
Association Between Radioactive Iodine Treatment for Pediatric and Young Adulthood Differentiated Thyroid Cancer and Risk of Second Primary Malignancies.
Pasqual, Elisa PhD 1; Schonfeld, Sara PhD 1; Morton, Lindsay M. PhD 1; Villoing, Daphnee PhD 2; Lee, Choonsik PhD 1; Berrington de Gonzalez, Amy DPhil 1; Kitahara, Cari M. PhD, MHS 1,
doi : 10.1200/JCO.21.01841
Mortality After Late Breast Cancer Recurrence in Denmark.
Pedersen, Rikke Norgaard MD 1; Mellemkjaer, Lene PhD 2,; Ejlertsen, Bent DMSc 3,; Norgaard, Mette PhD 1,; Cronin-Fenton, Deirdre P. PhD 1,
doi : 10.1200/JCO.21.02062
Effects of the WRITE Symptoms Interventions on Symptoms and Quality of Life Among Patients With Recurrent Ovarian Cancers: An NRG Oncology/GOG Study (GOG-0259).
Donovan, Heidi S. PhD, RN 1,2,; Sereika, Susan M. PhD 1; Wenzel, Lari B. PhD 3,; Edwards, Robert P. MD 2,; Knapp, Judith E. PhD 1; Hughes, Susan H. RN, MSN 4; Roberge, Mary C. RN, BSN 1,; Thomas, Teresa H. PhD, BA, RN 1,; Klein, Sara Jo MS, BSN 1; Spring, Michael B. PhD 5; Nolte, Susan PhD, RN 6; Landrum, Lisa M. MD, PhD 7; Casey, A. Catherine MD 8; Mutch, David G. MD 9,; DeBernardo, Robert L. MD 10; Muller, Carolyn Y. MD 11,; Sullivan, Stephanie A. MD 12; Ward, Sandra E. PhD, RN 4
doi : 10.1200/JCO.21.00656
Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials.
Unger, Joseph M. PhD 1,; Vaidya, Riha PhD 1; Albain, Kathy S. MD 2,; LeBlanc, Michael PhD 1,; Minasian, Lori M. MD 3; Gotay, Carolyn C. PhD 4,; Henry, N. Lynn MD, PhD 5,; Fisch, Michael J. MD 6,; Lee, Shing M. PhD 7,; Blanke, Charles D. MD 8; Hershman, Dawn L. MD, MS 7,
doi : 10.1200/JCO.21.02377
Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy.
Lagerlof, Ingemar MD 1,; Fohlin, Helena PhD 2; Enblad, Gunilla MD, PhD 1,; Glimelius, Bengt MD, PhD 1,; Goldkuhl, Christina MD 3; Palma, Marzia MD, PhD 4,; Akesson, Lisa BS 2; Glimelius, Ingrid MD, PhD 1,; Molin, Daniel MD, PhD 1,
doi : 10.1200/JCO.21.02407
Impact of a Novel Molecular Imaging Modality, Prostate-Specific Membrane Antigen Positron Emission Tomography, on the Management of Prostate Cancer.
Patel, Neal A. MD 1; Reiter, Robert E. MD, MBA 1,2,,
doi : 10.1200/JCO.21.02940
Considerations on Integrating Prostate-Specific Membrane Antigen Positron Emission Tomography Imaging Into Clinical Prostate Cancer Trials by National Clinical Trials Network Cooperative Groups.
Schoder, Heiko MD, MBA 1,; Hope, Thomas A. MD 2,; Knopp, Michael MD 3; Kelly, William K. DO 4,; Michalski, Jeff M. MD, MBA 5,; Lerner, Seth P. MD 6,; Tawab-Amiri, Abdul PhD 7; Mann, Bhupinder S. MBBS 8; Lin, Daniel W. MD 9,; Yu, Evan Y. MD 9,; Chen, Ronald C. MD, MPH 10,; Beach, Gillian C. PhD 11,; Reeves, Steven A. PhD 7; Members of the Working Group; Shankar, Lalitha K. MD, PhD 12
doi : 10.1200/JCO.21.02440
Regarding the Children's Oncology Group AEWS1031 Trial for Ewing Sarcoma.
Wang, Ji-Gan MD; Wei, Qiu-Fen MD; Tang, Qu-Mei MD
doi : 10.1200/JCO.21.02546
Reply to J.-G. Wang et al.
Leavey, Patrick J. MD; Krailo, Mark D. PhD; DuBois, Steven G. MD; Reed, Damon R. MD; Janeway, Katherine A. MD; Mascarenhas, Leo MD
doi : 10.1200/JCO.21.02922
Granulocyte Colony-Stimulating Factor Usage in Recipients of Chimeric Antigen Receptor T-Cell Immunotherapy.
Abid, Muhammad Bilal MD, MRCP
doi : 10.1200/JCO.21.02694
Reply to M.B. Abid.
Santomasso, Bianca MD, PhD; Ghosh, Monalisa MD; Schneider, Bryan MD; Bollin, Kathryn MD
doi : 10.1200/JCO.22.00225
